Published in Biotech Law Weekly, July 23rd, 2004
Under the terms of the settlement agreement executed effective June 21, 2004, Inamed will pay Ethicon $17,250,000 by June 26, 2004, and, pursuant to a license arrangement included in the settlement agreement, will pay royalties to Ethicon on future United States sales of the LAP-BAND System, initially at 7.5%. Prior to this settlement, Inamed has been accruing a royalty on U.S. sales at 1.2%. The 7.5%...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.